Breast Cancer Network Australia (BCNA) has welcomed a decision to recommend a new targeted treatment for metastatic breast cancer for PBS subsidy.
Clinical trials show the new medicine TRUQAP® (capivasertib), in combination with hormone blocking treatment fulvestrant, keeps cancer from growing or spreading for more than twice as long than fulvestrant alone.
The drug has been recommended for PBS sub...
